AGENT FOR TREATING CHRONIC INFLAMMATORY DISEASES OF URETHRA AND BLADDER Russian patent published in 2016 - IPC A61K9/10 A61K31/573 A61K31/167 A61K31/205 A61K31/718 A61K31/729 A61K31/727 A61P13/10 A61P13/02 

FIELD: pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry and medicine and represents an agent for treating chronic inflammatory diseases of the urethra and the bladder containing heparin, an analgesic substance and a base, characterized by that it additionally contains dexamethasone, as the analgesic substance - lidocaine, starch-agar gel as the base consisting of starch, agar-agar and purified water and myramistin as a stabilizer of the base, where heparin is contained in the agent in the amount of 22,750-25,500 IU, dexamethasone in the amount of 7.6-8.4 mg, lidocaine 2 % in the amount of 3.8-4.2 ml, starch in the amount of 0.33-0.40 g, agar-agar in the amount of 0.08-0.12 g, myramistin 0.01 % - 4-5 ml and purified water - 45-46 ml.

EFFECT: invention provides higher clinical effectiveness in chronic inflammatory diseases of urinary bladder and urethra, prolonged remission, reduced rate of recurrences, effective reduction or reversal of pain syndrome.

1 cl, 3 ex